Join the Albuterol group to help and get support from people like you.
Albuterol News
In Utero Corticosteroid Exposure Not Detrimental to Offspring Neurodevelopment
THURSDAY, Oct. 26, 2023 – In utero exposure to corticosteroids and β2-adrenergic agonists appears to not be associated with most offspring neurodevelopmental outcomes, according to a study published ...
Black Children With Asthma More Likely to Receive Bronchodilators From EMS
WEDNESDAY, Oct. 11, 2023 – Black children receiving emergency medical services (EMS) care are more likely to receive a bronchodilator than White children, according to a study published online Sept....
FDA Medwatch Alert: Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect
Mumbai, India July 6, 2023/ New Jersey, USA July 6, 2023 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US i...
FDA Medwatch Alert: FDA Alerts of Perrigo's Voluntary Albuterol Inhaler Recall
September 21, 2020 – The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured...
FDA Approves ProAir Digihaler (albuterol sulfate) as the First and Only Digital Inhaler with Built-In Sensors
JERUSALEM--(BUSINESS WIRE)--Dec 21, 2018--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir ® Digihaler™ (a...
Teva Announces FDA Approval of ProAir RespiClick (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11
JERUSALEM--(BUSINESS WIRE)--Apr. 29, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick...
Teva Announces FDA Approval of ProAir RespiClick
JERUSALEM--(BUSINESS WIRE)--Apr. 1, 2015-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol...
FDA Medwatch Alert: Albuterol Sulfate Inhalation Solution, 0.083 percent (Nephron Pharmaceuticals): Recall - Aseptic Processing Simulation Results
ISSUE: Nephron Pharmaceuticals initiated a voluntary recall, at the retail level, of ten lots of product due to results from an internal monitoring process. NPC performs aseptic process simulation...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Asthma - Acute, Asthma - Maintenance, Asthma, Chronic Obstructive Pulmonary Disease